Previous studies have demonstrated that the co-expression of two mutant G protein-coupled receptors (GPCRs) can potentially restore their impaired functionality. In this study, we investigated the rescue of functional deficits in homo- and heterodimers of α1B-adrenergic receptors (ARs) using a combination of biophysical and biochemical approaches. Initially, we constructed an Förster resonance energy transfer (FRET) sensor for α1B-AR that lacked ligand-binding capability (referred to as “silent”), and a mutant α1B-AR incapable of downstream activation (referred to as “defective”). Our results revealed that the co-expression of the “defective” and “silent” α1B-ARs led to the activation of the “silent” sensor and restoration of functional impairments in both receptors. Similarly, we conducted experiments involving the co-expression of a “defective” CXCR4 receptor lacking downstream signaling and G-protein recruitment with the “silent” α1B-AR FRET sensor, which also resulted in the rescue of their functional deficiencies. These findings highlight that upon dimerization with the “defective receptor, the “silent” receptor undergoes agonist-like structural changes, leading to functional restoration. This study provides direct evidence for the functional complementation mechanism mediated by GPCR dimers and offers new insights into the intervention strategies targeting GPCR defect-related diseases.
FascianiICarliMPetragnanoF, et al.GPCRs in intracellular compartments: new targets for drug discovery. Biomolecules2022; 12: 1–22.
2.
LiMLanXShiX, et al.Delineating the stepwise millisecond allosteric activation mechanism of the class C GPCR dimer mGlu5. Nat Commun2024; 15: 7519.
3.
LiuYShaoYTWardR, et al.The C-terminal of the α1b-adreneroceptor is a key determinant for its structure integrity and biological functions. Biosci Biotechnol Biochem2021; 85: 1128–1139.
4.
SakK. GPCRs as targets for flavonoids in cancer cells: new options for intervention. Explor Target Antitumor Ther2024; 5: 1155–1167.
5.
García-RecioANavarroGFrancoR, et al.DIMERBOW: exploring possible GPCR dimer interfaces. Bioinformatics2020; 36: 3271–3272.
6.
PatwardhanAChengNTrejoJ. Post-Translational modifications of G protein-coupled receptors control cellular signaling dynamics in space and time. Pharmacol Rev2021; 73: 120–151.
7.
Marquez-KlakaBRettingerJNickeA. Inter-subunit disulfide cross-linking in homomeric and heteromeric P2X receptors. Eur Biophys J2009; 38: 329–338.
8.
BusilloJMBenovicJL. Regulation of CXCR4 signaling. Biochim Biophys Acta2007; 1768: 952–963.
9.
MarcheseAChenCKimYM, et al.The ins and outs of G protein-coupled receptor trafficking. Trends Biochem Sci2003; 28: 369–376.
10.
MooreCAMilanoSKBenovicJL. Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol2007; 69: 451–482.
11.
FerreSCasadoVDeviLA, et al.G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacol Rev2014; 66: 413–434.
12.
RozenfeldRDeviLA. Receptor heteromerization and drug discovery. Trends Pharmacol Sci2010; 31: 124–130.
13.
TakayamaIArakiNTewariJ, et al.Antagonists enhance cell-surface expression of mammalian odorant receptors. Int J Mol Sci2025; 26: 1458–1472.
14.
ShenKWangQWangL, et al.Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma. Eur J Med Res2023; 28: 352.
15.
XuTRWardRJPedianiJD, et al.The orexin OX(1) receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands. Biochem J2011; 439: 171–183.
16.
Díaz VázquezGCuiQSenesA. Thermodynamic analysis of the GAS(right) transmembrane motif supports energetic model of dimerization. Biophys J2023; 122: 143–155.
17.
VidiPAEjendalKFPrzybylaJA, et al.Fluorescent protein complementation assays: new tools to study G protein-coupled receptor oligomerization and GPCR-mediated signaling. Mol Cell Endocrinol2011; 331: 185–193.
18.
ShyuYJHiattSMDurenHM, et al.Visualization of protein interactions in living caenorhabditis elegans using bimolecular fluorescence complementation analysis. Nat Protoc2008; 3: 588–596.
SanabriaHRodninDHemmenK. Resolving dynamics and function of transient states in single enzyme molecules. Nat Commun2020; 11: 1231.
21.
CardulloRA. Theoretical principles and practical considerations for fluorescence resonance energy transfer microscopy. Methods Cell Biol2007; 81: 479–494.
HebertTEMoffettSMorelloJP, et al.A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem1996; 271: 16384–16392.
24.
AbdrabouABrandweinDLiuC, et al.Rac1 S71 mediates the interaction between rac1 and 14-3-3 proteins. Cells 2019; 8: 1006–1024.
25.
AngersSSalahpourABouvierM. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol2002; 42: 409–435.
26.
GuoHAnSWardR, et al.Methods used to study the oligomeric structure of G-protein-coupled receptors. Biosci Rep2017; 37: 1–19.
27.
ShuklaAKWestfieldGHXiaoK, et al.Visualization of arrestin recruitment by a G-protein-coupled receptor. Nature2014; 512: 218–222.
28.
SöderbergOGullbergMJarviusM, et al.Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods2006; 3: 995–1000.
29.
AngersSSalahpourAJolyE, et al.Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A2000; 97: 3684–3689.
30.
GhoshASonavaneUJoshiR. Multiscale modelling to understand the self-assembly mechanism of human beta2-adrenergic receptor in lipid bilayer. Comput Biol Chem2014; 48: 29–39.
31.
GaoXAbdelkarimHAlbeeLJ, et al.Partial agonist activity of alpha1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3. PLoS One 2018; 13: e0204041.
32.
GorenAShapiroJSinclairR, et al.alpha1 -AR agonist induced piloerection protects against the development of traction alopecia. Dermatol Ther2016; 29: 160–163.
33.
WrightCDWuSCDahlEF, et al.Nuclear localization drives alpha1-adrenergic receptor oligomerization and signaling in cardiac myocytes. Cell Signal2012; 24: 794–802.
34.
MonnotCBihoreauCConchonS, et al.Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem1996; 271: 1507–1513.
35.
MohammadpourHMacDonaldCRQiaoG, et al.Β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest2019; 129: 5537–5552.
36.
MusayevaAManicamCSteegeA, et al.Role of alpha1-adrenoceptor subtypes on corneal epithelial thickness and cell proliferation in mice. Am J Physiol Cell Physiol2018; 315: C757–C765.
37.
BrueggemannLIMackieARCribbsLL, et al.Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels. J Biol Chem2014; 289: 2099–2111.
38.
TripathiADavisJDStarenDM, et al.CXC Chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1alpha and ubiquitin. Cytokine2014; 65: 121–125.
39.
TripathiAVanaPGChavanTS, et al.Heteromerization of chemokine (C-X-C motif) receptor 4 with alpha1A/B-adrenergic receptors controls alpha1-adrenergic receptor function. Proc Natl Acad Sci U S A2015; 112: E1659–E1668.
40.
MalikRMarcheseA. Arrestin-2 interacts with the endosomal sorting complex required for transport machinery to modulate endosomal sorting of CXCR4. Mol Biol Cell2010; 21: 2529–2541.
41.
RamsayDCarrICPedianiJ, et al.High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha1L-adrenoceptor. Mol Pharmacol2004; 66: 228–239.
42.
PapayRGaivinRMcCuneDF, et al.Mouse alpha1B-adrenergic receptor is expressed in neurons and NG2 oligodendrocytes. J Comp Neurol2004; 478: 1–10.
43.
KimHRDucNMChungKY. Comprehensive analysis of non-synonymous natural variants of G protein-coupled receptors. Biomol Ther (Seoul)2018; 26: 101–108.
44.
HagueCLeeSEChenZ, et al.Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity. Mol Pharmacol2006; 69: 45–55.
45.
GreasleyPJFanelliFScheerA, et al.Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. J Biol Chem2001; 276: 46485–46494.
46.
ZhangWBNavenotJMHaribabuB, et al.A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. J Biol Chem2002; 277: 24515–24521.
47.
PollokBAHeimR. Using GFP in FRET-based applications. Trends Cell Biol1999; 9: 57–60.
MilliganG. Oligomerisation of G-protein-coupled receptors. J Cell Sci2001; 114: 1265–1271.
50.
DeviLA. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci2001; 22: 532–537.
51.
GeorgeSRO’DowdBFLeeSP. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discovery2002; 1: 808–820.
52.
KobilkaBKKobilkaTSDanielK, et al.Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science1988; 240: 1310–1316.
53.
AlbeeLJEbyJMTripathiA, et al.α1-Adrenergic receptors function within hetero-oligomeric complexes with atypical chemokine receptor 3 and chemokine (C-X-C motif) receptor 4 in vascular smooth muscle cells. J Am Heart Assoc2017; 6: 1–17.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
